Product Specifications Research Overview PT-141, also indexed as bremelanotide, is a cyclic lactam heptapeptide analogue of alpha-melanocyte-stimulating hormone with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH (CHNO, 1025.2 g/mol, CAS 189691-06-3)
G., Canale, R
The FDA labels for GLP-1 medications list a higher chance of gallstones and gallbladder disease as a potential risk
Ideal candidates typically include: Body composition goals: Individuals focused on reducing body fat percentage while preserving lean muscle mass, those who have reached plateaus with diet and exercise alone, patients seeking metabolically selective approaches without growth hormones broader effects, or individuals interested in targeted fat reduction (particularly abdominal/visceral fat)
Mounjaro contains the same active ingredient as Zepbound, tirzepatide, but it is specifically approved for the treatment of type 2 diabetes, whereas Zepbound is approved for chronic weight management
It also soothes and softens the skin